Adopting an heterologous prime-boost strategy in COVID-19 vaccination: the need for locally generated evidence in Africa

The reduction in the severity and prevalence of COVID-19 has been largely due to the rapid development and deployment of COVID-19 vaccines. Consequently, WHO, in partnership with the Coalition for Epidemic Preparedness Innovation, GAVI, the Vaccine Alliance, set up the COVID-19 Vaccines Global Acces...

Descripción completa

Detalles Bibliográficos
Autores principales: Oboh, Mary Aigbiremo, Omoleke, Semeeh, Salami, Kolawole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046858/
https://www.ncbi.nlm.nih.gov/pubmed/35519174
http://dx.doi.org/10.11604/pamj.2022.41.148.31620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046858/
https://www.ncbi.nlm.nih.gov/pubmed/35519174
http://dx.doi.org/10.11604/pamj.2022.41.148.31620

Ejemplares similares